These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34883536)

  • 21. Menopause-specific quality of life of a group of urban women, West Bengal, India.
    Som N; Roy P; Ray S
    Climacteric; 2014 Dec; 17(6):713-9. PubMed ID: 24742367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.
    Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM
    Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasomotor symptom prevalence and language of menopause in Japan.
    Melby MK
    Menopause; 2005; 12(3):250-7. PubMed ID: 15879913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived control, lifestyle, health, socio-demographic factors and menopause: impact on hot flashes and night sweats.
    Pimenta F; Leal I; Maroco J; Ramos C
    Maturitas; 2011 Aug; 69(4):338-42. PubMed ID: 21680119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-Aged Health in Women from the Indian Subcontinent (MAHWIS): a further quantitative and qualitative investigation of experience of menopause in UK Asian women, compared to UK Caucasian women and women living in Delhi.
    Hunter MS; Gupta P; Papitsch-Clark A; Sturdee DW
    Climacteric; 2009 Feb; 12(1):26-37. PubMed ID: 19065308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with the CVD risk factors and body fat pattern of postmenopausal Hindu caste and Lodha tribal populations living in India: An exploratory study.
    Kar D; Roy S
    Womens Midlife Health; 2023 Apr; 9(1):4. PubMed ID: 37095574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial factors, attitude to menopause and symptoms in Swedish perimenopausal women.
    Olofsson AS; Collins A
    Climacteric; 2000 Mar; 3(1):33-42. PubMed ID: 11910608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies.
    Zhu D; Chung HF; Dobson AJ; Pandeya N; Anderson DJ; Kuh D; Hardy R; Brunner EJ; Avis NE; Gold EB; El Khoudary SR; Crawford SL; Mishra GD
    Am J Obstet Gynecol; 2020 Dec; 223(6):898.e1-898.e16. PubMed ID: 32585222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the variation in menopausal symptoms with age, education and working/non-working status in north-Indian sub population using menopause rating scale (MRS).
    Kakkar V; Kaur D; Chopra K; Kaur A; Kaur IP
    Maturitas; 2007 Jul; 57(3):306-14. PubMed ID: 17408889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying symptom clusters during the menopausal transition: observations from the Seattle Midlife Women's Health Study.
    Cray LA; Woods NF; Mitchell ES
    Climacteric; 2013 Oct; 16(5):539-49. PubMed ID: 23153001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study.
    Collins A; Landgren BM
    Maturitas; 1994 Dec; 20(2-3):101-11. PubMed ID: 7715461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
    Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
    J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?
    Greendale GA; Gold EB
    Am J Med; 2005 Dec; 118 Suppl 12B():148-54. PubMed ID: 16414341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of sociodemographic and reproductive variables with menopause-specific quality of life using principal component analysis.
    Som N; Roy P; Ray S
    Women Health; 2019 Feb; 59(2):155-170. PubMed ID: 29630474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review.
    Mejia-Gomez J; Phung N; Philippopoulos E; Murphy KE; Wolfman W
    Climacteric; 2021 Dec; 24(6):572-576. PubMed ID: 33759668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of menopause associated vasomotor symptoms and options available in its management.
    Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
    Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental contexts of menopause in Spain: comparative results from recent research.
    Bernis C; Reher DS
    Menopause; 2007; 14(4):777-87. PubMed ID: 17679148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between postmenopausal women's body image and the severity of menopausal symptoms.
    Nazarpour S; Simbar M; Majd HA; Torkamani ZJ; Andarvar KD; Rahnemaei F
    BMC Public Health; 2021 Aug; 21(1):1599. PubMed ID: 34461857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopause-specific quality of life during ovarian aging among Chinese women: A prospective cohort study.
    Tang R; Luo M; Fan Y; Peng Y; Wang Y; Liu G; Wang Y; Lin S; Chen R
    Maturitas; 2022 Mar; 157():7-15. PubMed ID: 35120675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.